Evidence map›Paper›PMID 41898713›Full record

ArticleInternational journal of molecular sciences2026

Zhen Chen, Fangjun Liu, Yixiao Cheng, Pengfei Li, Michael Rain Riggs, Wansheng Liu, Zhiwei Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhen ChenCollege of Life Science, Shanxi Agricultural University, Taigu, Jinzhong 030801, China.
Fangjun LiuCollege of Life Science, Shanxi Agricultural University, Taigu, Jinzhong 030801, China.
Yixiao ChengCollege of Life Science, Shanxi Agricultural University, Taigu, Jinzhong 030801, China.
Pengfei LiCollege of Life Science, Shanxi Agricultural University, Taigu, Jinzhong 030801, China.
Michael Rain RiggsDepartment of Animal Science, Center for Reproductive Biology and Health (CRBH), College of Agricultural Sciences, The Pennsylvania State University, University Park, PA 16802, USA.ORCID 0009-0009-8431-8035
Wansheng LiuDepartment of Animal Science, Center for Reproductive Biology and Health (CRBH), College of Agricultural Sciences, The Pennsylvania State University, University Park, PA 16802, USA.ORCID 0000-0003-1788-7093
Zhiwei ZhuCollege of Life Science, Shanxi Agricultural University, Taigu, Jinzhong 030801, China.ORCID 0000-0002-1727-5727

Funding

Zhiwei Zhu Grant No.202303021221094Zhiwei Zhu Grant No.202503021211173Zhiwei Zhu Grant Nos. 31402156Zhiwei Zhu Grant Nos. 31873002
6 · The paper itself

Abstract

Melanoma is an aggressive skin cancer with high metastatic potential and poor long-term survival, highlighting the need for new therapeutic targets. Although microRNAs are critical regulators of tumor progression, the function of

Indexed as

MAP Kinase Signaling SystemMelanomaMicroRNAsTumor MicroenvironmentVascular Endothelial Growth Factor CAnimalsCell Line, TumorCell MovementCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticHumansMiceNeovascularization, PathologicMicroRNAsMIRN374 microRNA 374, humanVascular Endothelial Growth Factor CVEGFC protein, humanMAPKmelanomamiR-374b-5ptumor microenvironmentVEGFC

Identifiers

PMID41898713
PMCPMC13026663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.